Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families

Abstract Introduction The impact of crisaborole ointment, a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate atopic dermatitis (AD), on quality of life (QoL) was assessed in two identically designed phase 3 studies (AD-301: NCT02118766; AD-302: NCT02118792, both at ht...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Eric L. Simpson, Amy S. Paller, Mark Boguniewicz, Lawrence F. Eichenfield, Steven R. Feldman, Jonathan I. Silverberg, Sarah L. Chamlin, Lee T. Zane
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Adis, Springer Healthcare 2018-10-01
coleção:	Dermatology and Therapy
Assuntos:	Atopic dermatitis Crisaborole Eczema PDE4 Phosphodiesterase 4 Quality of life
Acesso em linha:	http://link.springer.com/article/10.1007/s13555-018-0263-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!